PLoS Medicine · 2013 · 47 citations · 9 references
PharmacyHealth PolicyPharmaceutical PolicyHealth Technology AssessmentPatient SafetyPharmacovigilanceMedical Device Adverse Event ReportingMedical Device SafetyPost-market SurveillancePost-marketing Safety SurveillancePostmarket SurveillanceSurveillance EvaluationDevice-related Adverse Event ReportingMarketplace SurveillancePassive Data CollectionPost-market Safety SurveillancePost-marketing Drug Safety SurveillancePost-marketing SurveillancePostmarketing Adverse Event SurveillancePostmarketing Safety Surveillance
We evaluated strategies for postmarket surveillance of medical devices in the United States, European Union, Japan, and China.
9